Table 1.
Baseline and clinical characteristics of the two groups before intervention.
| Parameters | Exercise group (n = 15) | Control group (n = 16) | p value |
|---|---|---|---|
| Age (years) | 54.9 ± 4.7 | 55.2 ± 4.3 | 0.854 |
| Sex, n (%) | |||
| Men | 8 (53.3) | 9 (56.2) | 0.843 |
| Women | 7 (46.7) | 7 (43.8) | |
| BMI (kg/m2) | 36.7 ± 3.4 | 35.9 ± 5.3 | 0.629 |
| Clinical characteristics | |||
| Intrahepatic triglyceride (%) | 12.9 ± 4.2 | 11.2 ± 5.1 | 0.349 |
| Visceral adipose fat (cm2) | 181.7 ± 13.5 | 179.8 ± 14.4 | 0.708 |
| Total triglycerides (mg/dL) | 196.5 ± 12.6 | 198.1 ± 11.8 | 0.718 |
| Total cholesterol (mg/dL) | 193.2 ± 8.8 | 188.3 ± 8.4 | 0.123 |
| HDL-cholesterol (mg/dL) | 37.5 ± 3.4 | 38.5 ± 3.3 | 0.421 |
| LDL-cholesterol (mg/dL) | 98.4 ± 5.7 | 95.2 ± 4.8 | 0.101 |
| AL (IU/L) | 44.6 ± 5.1 | 43.5 ± 4.6 | 0.533 |
| HOMA-IR | 4.7 ± 1.4 | 4.8 ± 1.5 | 0.704 |
| HbA1c (%) | 6.4 ± 0.5 | 6.7 ± 0.6 | 0.143 |
Sig.: significance level at p < 0.05. BMI: body mass index. HDL: high-density lipoproteins. LDL: low-density lipoprotein. AL: alanine transaminase. HOMA-IR: homeostatic model assessment-insulin resistance. HbA1c: glycated hemoglobin.